TrialActa oncologica (Stockholm, Sweden)2024

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.

Helena Fohlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.